Focusing on quality patient care in the new global subsidy for malaria medicines.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 19621068.
- Also identified by DOI 10.1371/journal.pmed.1000106 and PMC identifier 2706998.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Tido von Schoen-Angerer and colleagues discuss the new Affordable Medicines Facility for malaria (AMFm), which subsidizes and facilitates access to artemisinin-based combination therapy, and what mechanisms are needed to ensure it stays focused on quality patient care.
Medical subject headings
- Antimalarials
- Artemisinins
- Delivery of Health Care
- Financing, Organized
- Health Services Accessibility
- International Cooperation
- Malaria, Falciparum
- Quality of Health Care